Veracyte, Inc. (VCYT) by event type
VCYT moves most on analyst upgrades — a median of +0.68% at 30 minutes across 16 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the VCYT overview →
How VCYT reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 242 of 2,717 | 16 | +0.68% | 69% | +0.67% |
| Analyst downgrades 1,476 of 2,603 | 13 | -0.02% | 46% | +0.82% |
| Coverage initiations 825 of 2,283 | 22 | +0.14% | 64% | +0.80% |
| Rating reiterations 1,039 of 3,522 | 80 | +0.07% | 56% | -0.12% |
| Price-target raises 1,664 of 1,790 | 16 | -0.32% | 31% | -1.23% |
| Price-target cuts 1,348 of 1,527 | 13 | -0.27% | 39% | +0.96% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how VCYT usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · VCYT overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TRULIEVE CANNABIS CORP (TCNNF) | 429 | +0.41% | 58% |
| Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) | 427 | -0.21% | 39% |
| Moleculin Biotech, Inc. (MBRX) | 426 | -0.21% | 43% |
| Summit Therapeutics Inc. (SMMT) | 426 | +0.03% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.